Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pseudomonas aeruginosa Ribonuclease HII (rnhB) CSB-YP409432PZL
CSB-EP409432PZL
CSB-BP409432PZL
CSB-MP409432PZL
CSB-EP409432PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 5'-nucleotidase surE (surE) CSB-YP409433PZL
CSB-EP409433PZL
CSB-BP409433PZL
CSB-MP409433PZL
CSB-EP409433PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L31 type B (rpmE2) CSB-YP409434PZL
CSB-EP409434PZL
CSB-BP409434PZL
CSB-MP409434PZL
CSB-EP409434PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Probable 4-deoxy-4-formamido-L-arabinose-phosphoundecaprenol deformylase ArnD (arnD) CSB-YP409435PZL
CSB-EP409435PZL
CSB-BP409435PZL
CSB-MP409435PZL
CSB-EP409435PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Alginate lyase (algL) CSB-YP409436PZL
CSB-EP409436PZL
CSB-BP409436PZL
CSB-MP409436PZL
CSB-EP409436PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Electron transport complex protein RnfD (rnfD), partial CSB-YP409437PZL
CSB-EP409437PZL
CSB-BP409437PZL
CSB-MP409437PZL
CSB-EP409437PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa UPF0060 membrane protein PSPA7_1846 (PSPA7_1846), partial CSB-YP409438PZL1
CSB-EP409438PZL1
CSB-BP409438PZL1
CSB-MP409438PZL1
CSB-EP409438PZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Formimidoylglutamase (hutG) CSB-YP409439PZL
CSB-EP409439PZL
CSB-BP409439PZL
CSB-MP409439PZL
CSB-EP409439PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Glutamate--tRNA ligase (gltX) CSB-YP409440PZL
CSB-EP409440PZL
CSB-BP409440PZL
CSB-MP409440PZL
CSB-EP409440PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Deoxyguanosinetriphosphate triphosphohydrolase-like protein (PSPA7_2095) CSB-YP409441PZL
CSB-EP409441PZL
CSB-BP409441PZL
CSB-MP409441PZL
CSB-EP409441PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Na (+)-translocating NADH-quinone reductase subunit E, partial CSB-YP409442PZL1
CSB-EP409442PZL1
CSB-BP409442PZL1
CSB-MP409442PZL1
CSB-EP409442PZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L32 (rpmF) CSB-YP409443PZL
CSB-EP409443PZL
CSB-BP409443PZL
CSB-MP409443PZL
CSB-EP409443PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Protease HtpX (htpX), partial CSB-YP409444PZL1
CSB-EP409444PZL1
CSB-BP409444PZL1
CSB-MP409444PZL1
CSB-EP409444PZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Integration host factor subunit alpha (ihfA) CSB-YP409445PZL
CSB-EP409445PZL
CSB-BP409445PZL
CSB-MP409445PZL
CSB-EP409445PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP409446PZL
CSB-EP409446PZL
CSB-BP409446PZL
CSB-MP409446PZL
CSB-EP409446PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 1,4-alpha-glucan branching enzyme GlgB (glgB), partial CSB-YP409447PZL
CSB-EP409447PZL
CSB-BP409447PZL
CSB-MP409447PZL
CSB-EP409447PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Undecaprenyl-diphosphatase (uppP), partial CSB-YP409448PZL1
CSB-EP409448PZL1
CSB-BP409448PZL1
CSB-MP409448PZL1
CSB-EP409448PZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase (fabA) CSB-YP409449PZL
CSB-EP409449PZL
CSB-BP409449PZL
CSB-MP409449PZL
CSB-EP409449PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa DNA ligase (ligA), partial CSB-YP409450PZL
CSB-EP409450PZL
CSB-BP409450PZL
CSB-MP409450PZL
CSB-EP409450PZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Cobalamin synthase (cobS), partial CSB-YP409451PZL1
CSB-EP409451PZL1
CSB-BP409451PZL1
CSB-MP409451PZL1
CSB-EP409451PZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>